<DOC>
	<DOCNO>NCT01657097</DOCNO>
	<brief_summary>Allergic rhinitis common condition cause inflammation nasal mucosa . The study perform gain information inflammation , include effect intranasal corticosteroid treatment hereupon potential influence lower airway , ie asthma . The study randomise , placebo-controlled double-blind patient , monoallergic grasspollen , present symptom rhinitis asthma season . Treatment , ie intranasal corticosteroid placebo , give four week . After two week treatment intranasal allergen challenge perform . Measurements perform full study period . The study perform pollen season .</brief_summary>
	<brief_title>Allergic Inflammation Rhinitis Patients Following Nasal Allergen Challenge</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>monoallergy grass symptom allergic rhinitis least two recent grasspollen season asthma symptom asthma least two four recent grasspollen season age 18 old pregnancy lactation fertile woman , sterilise use sufficient anticonception Corticosteroid treatment ( parenteral , oral , inhaled intranasal ) within two month prior enrolment Any disease , condition treatment , discretion investigator potential interfere study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>